368 related articles for article (PubMed ID: 17509291)
21. Risk of bilateral renal cell cancer.
Wiklund F; Tretli S; Choueiri TK; Signoretti S; Fall K; Adami HO
J Clin Oncol; 2009 Aug; 27(23):3737-41. PubMed ID: 19597028
[TBL] [Abstract][Full Text] [Related]
22. The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy.
Li WM; Li CC; Ke HL; Wu WJ; Huang CN; Huang CH
J Urol; 2009 Aug; 182(2):451-8; discussion 458. PubMed ID: 19524962
[TBL] [Abstract][Full Text] [Related]
23. Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score.
Thompson RH; Leibovich BC; Lohse CM; Cheville JC; Zincke H; Blute ML; Frank I
J Urol; 2007 Feb; 177(2):477-80. PubMed ID: 17222614
[TBL] [Abstract][Full Text] [Related]
24. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
[TBL] [Abstract][Full Text] [Related]
25. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC
Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844
[TBL] [Abstract][Full Text] [Related]
26. Age at diagnosis is an independent predictor of small renal cell carcinoma recurrence-free survival.
Jeong IG; Yoo CH; Song K; Park J; Cho YM; Song C; Hong JH; Ahn H; Kim CS
J Urol; 2009 Aug; 182(2):445-50. PubMed ID: 19524959
[TBL] [Abstract][Full Text] [Related]
27. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors for renal cell carcinoma with tumor thrombus extension.
Klatte T; Pantuck AJ; Riggs SB; Kleid MD; Shuch B; Zomorodian N; Kabbinavar FF; Belldegrun AS
J Urol; 2007 Oct; 178(4 Pt 1):1189-95; discussion 1195. PubMed ID: 17698087
[TBL] [Abstract][Full Text] [Related]
29. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma.
Sorbellini M; Kattan MW; Snyder ME; Reuter V; Motzer R; Goetzl M; McKiernan J; Russo P
J Urol; 2005 Jan; 173(1):48-51. PubMed ID: 15592023
[TBL] [Abstract][Full Text] [Related]
30. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
31. Prognosis and characteristics of renal cell carcinoma in hemodialysis patients: bilateral occurrence does not influence cancer-specific survival.
Takagi T; Kondo T; Izuka J; Kobayashi H; Tomita E; Hashimoto Y; Tanabe K
Int J Urol; 2011 Dec; 18(12):806-12. PubMed ID: 21917022
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.
Peycelon M; Hupertan V; Comperat E; Renard-Penna R; Vaessen C; Conort P; Bitker MO; Chartier-Kastler E; Richard F; Rouprêt M
J Urol; 2009 Jan; 181(1):35-41. PubMed ID: 19012929
[TBL] [Abstract][Full Text] [Related]
33. No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma?
Kwak C; Park YH; Jeong CW; Lee SE; Ku JH
Urol Oncol; 2007; 25(4):310-6. PubMed ID: 17628297
[TBL] [Abstract][Full Text] [Related]
34. Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survival.
Taccoen X; Valeri A; Descotes JL; Morin V; Stindel E; Doucet L; Joulin V; Bocqueraz F; Coulange C; Rambeaud JJ; Fournier G; Mejean A;
Eur Urol; 2007 Apr; 51(4):980-7. PubMed ID: 17092632
[TBL] [Abstract][Full Text] [Related]
35. Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients.
Antonelli A; Cozzoli A; Simeone C; Zani D; Zanotelli T; Portesi E; Cosciani Cunico S
BJU Int; 2006 Mar; 97(3):505-8. PubMed ID: 16469016
[TBL] [Abstract][Full Text] [Related]
36. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
Pahernik S; Cudovic D; Roos F; Melchior SW; Thüroff JW
BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
[TBL] [Abstract][Full Text] [Related]
37. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
[TBL] [Abstract][Full Text] [Related]
38. C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy.
Casamassima A; Picciariello M; Quaranta M; Berardino R; Ranieri C; Paradiso A; Lorusso V; Guida M
J Urol; 2005 Jan; 173(1):52-5. PubMed ID: 15592024
[TBL] [Abstract][Full Text] [Related]
39. [Bilateral renal cell carcinoma of von Hippel-Lindau disease associated with von Willebrand disease: a case report].
Tsuzuki M; Tochimoto M; Tsujino S; Akiyama A; Aizawa T; Ohno Y; Yamamoto S; Noda K; Miki M
Hinyokika Kiyo; 1995 Sep; 41(9):679-82. PubMed ID: 7484532
[TBL] [Abstract][Full Text] [Related]
40. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass.
Levinson AW; Su LM; Agarwal D; Sroka M; Jarrett TW; Kavoussi LR; Solomon SB
J Urol; 2008 Aug; 180(2):499-504; discussion 504. PubMed ID: 18550123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]